RecruitingNCT06799273

MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis

Studying Wild type ATTR amyloidosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centro Cardiologico Monzino
Enrollment
1400 enrolled
Eligibility
18-100 years · All sexes
Timeline
20242027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06799273 on ClinicalTrials.gov

Other trials for Wild type ATTR amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Wild type ATTR amyloidosis

← Back to all trials